Global Pain Management Devices Market Size By Product (Electrical Stimulators, Radiofrequency Ablation (RFA)), By Application (Cancer, Neuropathic Pain), By Geographic Scope And Forecast
Published on: 2024-08-07 | No of Pages : 320 | Industry : latest updates trending Report
Publisher : MIR | Format : PDF&Excel
Global Pain Management Devices Market Size By Product (Electrical Stimulators, Radiofrequency Ablation (RFA)), By Application (Cancer, Neuropathic Pain), By Geographic Scope And Forecast
Pain Management Devices Market Size And Forecast
Pain Management Devices Market size was valued at USD 3395 Million in 2021 and is projected to reach USD 7064 Million by 2030, growing at a CAGR of 8.49% from 2022 to 2030.
The increasing prevalence of chronic diseases is anticipated to be one of the primary factors driving market growth over the forecast period. Demand for muscle and nerve stimulators has increased due to the rising prevalence of lifestyle conditions such as obesity and diabetes. The rising prevalence of trauma or hypertension is likely to be another significant element driving the market growth. Hypertension increases the risk of brain aneurysms and other chronic disorders considerably. The Global Pain Management Devices Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.
Global Pain Management Devices Market Definition
Pain is a distressing sensory and emotional experience produced by tissue injury or disease. Injuries and other diseases, such as osteoarthritis, chronic arthritis, diabetic neuropathy, multiple sclerosis, stomach ulcer, fibromyalgia, and cancer, are responsible for this condition. Pain can be characterized as either acute or chronic based on its length. Acute pain is characterized by quick onset, whereas chronic pain remains for extended periods. Chronic pain is mostly caused by degenerative bone and joint disorders as well as nerve damage and injury.
A certain set of medications or equipment are used to treat pain. Pain management devices include transcutaneous electrical nerve stimulators, neuro-stimulators, analgesic infusion pumps, and radiofrequency ablators. The majority of these devices block the pain gate mechanism, preventing pain signals from reaching the brain. Similar to how radiofrequency ablators kill neurons by generating heat to prevent pain signals, neuro-stimulator devices employ low-frequency electrical current to block the passage of pain signals. These devices aid in the treatment of a variety of painful illnesses, including cancer, musculoskeletal injury, and neuropathy. Pain management devices lower the likelihood of long-term use of narcotics, nonsteroidal anti-inflammatory medicines, and other pain relievers.
Global Pain Management Devices Market Overview
The growth drivers for the market are rising demand for chronic pain management in-home care settings, a growing number of surgical procedures performed, the prevalence of neurological disorders, growing incidence of sports injuries and cancer, and established reimbursement scenarios for spinal cord stimulation (SCS) devices in developed countries. There has been a huge increase in the number of surgical procedures performed worldwide throughout the years. This is due to the growing elderly population and the prevalence of obesity and other lifestyle disorders. One of the leading causes of cardiovascular and orthopedic illnesses is obesity.
The principal application of infusion pumps is analgesia/pain control. Local delivery of narcotic analgesics and anesthetics following bariatric surgery, cardiothoracic surgery, and laparoscopic cholecystectomy is also commonly performed with infusion pumps. PCA pumps are used to relieve postoperative pain in a variety of orthopedic operations, including spine surgery, major joint surgery, and foot/lower extremity surgery. According to the 2016 National Spinal Cord Injury Statistical Center (NSCISC) datasheet, the incidence of spinal cord injuries (SCI) in the United States is roughly 54 cases per million people or approximately 17,000 new SCI cases annually.
More than 51 million inpatient surgical procedures are conducted annually in the United States, according to the National Center for Biotechnology Information (NCBI), and nearly 90 percent of hospitalized patients receive their drugs intravenously. With an increase in the number of surgical procedures, it is anticipated that the demand for infusion therapy will rise. The restraints for the market growth are product recalls and high procedural and purchase costs of pain management devices. Whereas the opportunities are High growth prospects in emerging nations, expanding the number of pain management clinics and centers worldwide, the Utilization of pain medicines as the initial treatment for pain, and Strict regulatory constraints hinder the introduction of innovative medical gadgets.
Global Pain Management Devices MarketSegmentation Analysis
The Global Pain Management Devices Market is Segmented on the basis of Product, Application, And Geography.
Pain Management Devices Market, By Product
• Electrical Stimulators• Radiofrequency Ablation (RFA)• Analgesic Infusion Pumps• Neurostimulation
Based on Product, The market is segmented into Electrical Stimulators, Radiofrequency Ablation (RFA), Analgesic Infusion Pumps, and Neurostimulation. Neurostimulation represents the greatest portion of the market. Increased prevalence of neurological illnesses is responsible for the growth. These neurostimulators are crucial in the treatment of chronic pain, Parkinson’s disease, epilepsy, movement disorders, and depression. In addition, the market is predicted to be driven by the launch of technologically sophisticated products, increased product demand, and the aging population.
Pain Management Devices Market, By Application
• Cancer• Neuropathic Pain• Facial & Migraine• Musculoskeletal Disorder• Trauma• Others
Based on Application, The market is segmented into Cancer, Neuropathic Pain, Facial & Migraine, Musculoskeletal Disorder, Trauma, and Others. The neuropathic pain market category is dominant. The expansion can be linked to the increasing prevalence of the target audience and the increased efforts of industry participants.
Pain Management Devices Market, By Geography
• North America• Europe• Asia Pacific• Rest of the world
On the basis of Geography, The Global Pain Management Devices Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. During the period of projection, North America is anticipated to expand at a healthy CAGR. In the healthcare industry, North America has been a leader in the development of devices and services for pain management. Due to the increasing incorporation of pain management devices in ambulatory care centers, the market for pain management devices in the United States is expected to experience growth in the coming years. The United States has become a hub for innovation in the market for pain management devices as a result of the presence of many of the world’s largest pain management device manufacturers.
Key Players
The “Global Pain Management Devices Market” study report will provide a valuable insight with an emphasis on the global market including some of the major players such as Medtronic PLC, Boston Scientific, Abbott, Becton, Dickinson and Company, Baxter International, B. Braun Melsungen AG, Stryker, Smiths Medical, Moog Inc., among others.
Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.
Key Developments
• In January 2020, Medtronic released Efficio, a cloud-based data management software designed to work with the SynchroMed II intrathecal drug delivery system. This enables clinicians to manage their targeted drug delivery pump practices efficiently to treat patients with chronic pain, cancer, and severe spasticity.
• In November 2020, Abbott introduced the IonicRF Generator, a minimally invasive device that targets specific nerves with heat for the treatment of chronic pain.
Report Scope
REPORT ATTRIBUTES | DETAILS |
---|---|
Study Period | 2018-2030 |
Base Year | 2021 |
Forecast Period | 2022-2030 |
HISTORICAL PERIOD | 2018-2020 |
UNIT | Value (USD Million) |
Key Companies Profiled | Medtronic PLC, Boston Scientific, Abbott, Becton, Dickinson and Company, Baxter International, B. Braun Melsungen AG, Stryker. |
Segments Covered | • By Product |
Customization scope | Free report customization (equivalent up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope. |
Top Trending Reports
Research Methodology of Market Research
To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .
Reasons to Purchase this Report
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support
Customization of the Report
• In case of any please connect with our sales team, who will ensure that your requirements are met.